Panic Disorder
Panic disorder is a type of anxiety disorder characterized by recurrent, unexpected panic attacks, which are sudden periods of intense fear that peak within minutes and involve symptoms such as palpitations, sweating, chest pain, dizziness, and shortness of breath. These attacks often lead to ongoing concern about future episodes and avoidance of places where previous attacks have occurred.
Health Outcomes
- Activation of Stress Response Pathways
- Altered Brain Activity to Negative Emotional Stimuli
- Changed Heart Rate
- Elevated Pulse Rate Under Stress
- Enhanced Autonomic Activity Total Power
- Enhanced Autonomic Function
- Enhanced Autonomic Nervous System Activity
- Enhanced Parasympathetic Nervous System Activity
- Enhanced Serotonin Pathway Function
- Enhanced Threat Response Appropriateness
- Improved Antidepressant Response
- Improved Anxiety Symptoms
- Improved Autonomic Balance
- Improved Behavioral Elements
- Improved Behavioral Health
- Improved Coping Strategies
- Improved Distress of Life Score
- Improved Emotional Behavior
- Improved Emotional Function
- Improved Emotional Processing
- Improved Emotional State
- Improved Emotional Well-Being Quality of Life
- Improved Emotional Well-being
- Improved General Behavioral Scores
- Improved Global Improvement of Symptoms (Clinician-Rated)
- Improved Mental Health
- Improved Mood
- Improved Parasympathetic Activity
- Improved Perceived Mental Well-being
- Improved Positive Mood Under Stress
- Improved Positive Well-Being
- Improved Psychological Distress
- Improved Psychological Function
- Improved Psychological Status
- Improved Psychological Well-being
- Improved Psychosocial Domain Score
- Improved Role Emotional
- Improved Serotonin Metabolism
- Improved Socialization
- Improved Stress Response
- Improved Stress Tolerance
- Improved Stress-Related Psychiatric Health
- Improved Sympathetic Tone
- Improved Total DASS-42 Score
- Increased 5-Hydroxytryptophan Levels
- Increased Brain GABA Levels
- Increased Cholecystokinin Level
- Increased GABA Production
- Increased GABAergic Signaling
- Increased Heart Rate
- Increased Heart Rate Response to Stress
- Increased Hypocapnic Hyperventilation Area Time
- Increased Jitteriness
- Increased Serotonin Production
- Increased Serum Serotonin Levels
- Increased Speed
- Increased Systemic GABA Levels
- Increased Treatment Responders
- No Reduction in Stress or Anxiety
- Reduced 5-Hydroxytryptamine Level
- Reduced ADAM Symptomatology Score
- Reduced Anxiety
- Reduced Anxiety Biomarkers
- Reduced Anxiety Levels
- Reduced Anxiety Responses
- Reduced Anxiety Scores
- Reduced Anxiety Symptoms
- Reduced Anxiety-Related Biomarkers
- Reduced Anxiety-Related Physiological Changes
- Reduced Anxiety-like Behavior
- Reduced Carbon Dioxide Partial Pressure
- Reduced Clinically Relevant Anxiety
- Reduced DASS-21 Score
- Reduced Depression Anxiety Stress Symptoms
- Reduced Depression and Anxiety Scores
- Reduced Episode Frequency
- Reduced HADS Global Score
- Reduced Incidence of Crying
- Reduced Limbic System Reactivity
- Reduced Mental Health Symptom
- Reduced Negative Emotional Responses
- Reduced Negative Mood States
- Reduced Palpitation
- Reduced Palpitation Symptoms
- Reduced Performance Choking Under Pressure
- Reduced Pre-Examination Physical Symptoms
- Reduced Psychiatric Problems
- Reduced Psychological Distress
- Reduced Psychological Score
- Reduced Psychopathology Symptoms
- Reduced Psychosocial Symptom
- Reduced Risk of Crying
- Reduced Salivary Chromogranin A Levels
- Reduced Salivary Serotonin Levels in Response to Stress
- Reduced Serum Serotonin Levels
- Reduced Stress Biomarkers
- Reduced Stress Indicators
- Reduced Stress Levels
- Reduced Stress Markers
- Reduced Stress Response
- Reduced Stress Scores
- Reduced Stress-Induced Anxiety
- Reduced Stress-Induced Sleep Disruption
- Reduced Stress-Related Discomfort
- Reduced Subjective Academic Stress
- Reduced Subjective Stress Levels
- Reduced Sympathetic Hyperactivity